IT8821535A0 - Derivati 4' fosfato di glucosidi della epipodofillotossina e relative composizioni farmaceutiche. - Google Patents

Derivati 4' fosfato di glucosidi della epipodofillotossina e relative composizioni farmaceutiche.

Info

Publication number
IT8821535A0
IT8821535A0 IT8821535A IT2153588A IT8821535A0 IT 8821535 A0 IT8821535 A0 IT 8821535A0 IT 8821535 A IT8821535 A IT 8821535A IT 2153588 A IT2153588 A IT 2153588A IT 8821535 A0 IT8821535 A0 IT 8821535A0
Authority
IT
Italy
Prior art keywords
epipodophyllotoxin
glucosides
pharmaceutical compositions
phosphate derivatives
related pharmaceutical
Prior art date
Application number
IT8821535A
Other languages
English (en)
Other versions
IT1226825B (it
Inventor
Mark G Saulnier
Peter D Senter
John F Kadow
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of IT8821535A0 publication Critical patent/IT8821535A0/it
Application granted granted Critical
Publication of IT1226825B publication Critical patent/IT1226825B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Mechanical Coupling Of Light Guides (AREA)
  • Cable Accessories (AREA)
IT8821535A 1987-08-04 1988-07-28 Derivati 4' fosfato di glucosidi della epipodofillotossina e relative composizioni farmaceutiche. IT1226825B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8149387A 1987-08-04 1987-08-04
US07/199,731 US4904768A (en) 1987-08-04 1988-05-27 Epipodophyllotoxin glucoside 4'-phosphate derivatives

Publications (2)

Publication Number Publication Date
IT8821535A0 true IT8821535A0 (it) 1988-07-28
IT1226825B IT1226825B (it) 1991-02-19

Family

ID=26765636

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8821535A IT1226825B (it) 1987-08-04 1988-07-28 Derivati 4' fosfato di glucosidi della epipodofillotossina e relative composizioni farmaceutiche.

Country Status (34)

Country Link
US (3) US4904768A (it)
JP (1) JPH0699465B2 (it)
KR (1) KR900006230B1 (it)
CN (1) CN1027169C (it)
AT (1) AT398974B (it)
BE (1) BE1002982A4 (it)
CA (1) CA1310637C (it)
CH (1) CH676716A5 (it)
CY (1) CY1625A (it)
CZ (1) CZ286893B6 (it)
DD (2) DD299067A5 (it)
DE (1) DE3826562A1 (it)
DK (2) DK169344B1 (it)
ES (1) ES2010775A6 (it)
FI (1) FI87790C (it)
FR (1) FR2622193B1 (it)
GB (1) GB2207674B (it)
GR (1) GR1000490B (it)
HK (1) HK6392A (it)
HU (3) HU202547B (it)
IE (1) IE61040B1 (it)
IL (1) IL87290A (it)
IT (1) IT1226825B (it)
LU (2) LU87290A1 (it)
MX (1) MX173843B (it)
MY (1) MY104321A (it)
NL (2) NL192683C (it)
NO (4) NO170284C (it)
NZ (1) NZ225615A (it)
PT (1) PT88186B (it)
SE (1) SE502214C2 (it)
SG (1) SG101291G (it)
SK (1) SK279325B6 (it)
YU (3) YU143688A (it)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5191071A (en) * 1987-08-21 1993-03-02 Novo Nordisk A/S Monoesters of glycosides and a process for enzymatic preparation thereof
US4965348A (en) * 1989-05-19 1990-10-23 Bristol-Myers Company Dimeric epipodophyllotoxin glucoside derivatives
US5036055A (en) * 1989-06-07 1991-07-30 Bristol-Myers Company Acylated derivatives of etoposide
US5066645A (en) * 1989-09-01 1991-11-19 Bristol-Myers Company Epipodophyllotoxin altroside derivatives
US6610299B1 (en) 1989-10-19 2003-08-26 Aventis Pharma Deutschland Gmbh Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
US7241595B2 (en) 1989-10-20 2007-07-10 Sanofi-Aventis Pharma Deutschland Gmbh Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
US6475486B1 (en) 1990-10-18 2002-11-05 Aventis Pharma Deutschland Gmbh Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
US5552154A (en) * 1989-11-06 1996-09-03 The Stehlin Foundation For Cancer Research Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof
US5034380A (en) * 1989-11-20 1991-07-23 Bristol-Myers Squibb Company Alkoxymethylidene epipodophyllotoxin glucosides
US5081234A (en) * 1990-04-30 1992-01-14 Bristol-Myers Squibb Co. 4'-demethylepipodophyllotoxin glycosides
US4997931A (en) * 1990-06-11 1991-03-05 Bristol-Myers Squibb Company Epipodophyllotoxin glycosides
TW260671B (it) * 1991-04-29 1995-10-21 Bristol Myers Squibb Co
IT1250692B (it) * 1991-07-23 1995-04-21 Procedimento per la preparazione di demetilepipodofillotossina- beta-d-glucosidi.
US5648474A (en) * 1991-10-08 1997-07-15 Bristol-Myers Squibb Crystalline etoposide 4'-phosphate diethanolate
CA2085520C (en) * 1991-12-23 1996-07-16 Uday Shankar Gogate Stable hexahydrate of etoposide 4'-phosphate disodium salt
US6080751A (en) * 1992-01-14 2000-06-27 The Stehlin Foundation For Cancer Research Method for treating pancreatic cancer in humans with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof
JP3061476B2 (ja) * 1992-04-24 2000-07-10 日本化薬株式会社 エトポシド燐酸エステルの製造法
US5459248A (en) * 1993-11-04 1995-10-17 Bristol-Myers Squibb Company Process of preparing etoposide phosphate and etoposide
FR2725990B1 (fr) * 1994-10-21 1997-01-10 Pf Medicament Derives hydrosolubles d'epipodophyllotoxine, leur procede de preparation, leur utilisation a titre de medicament, et leur utilisation destinee aux traitements anticancereux
US5942386A (en) * 1995-06-07 1999-08-24 Thomas Jefferson University Anti-fungal agents and methods of identifying and using the same
EP0907379B1 (en) 1996-04-01 2004-06-02 Epix Medical, Inc. Bioactivated diagnostic imaging contrast agents
US6207673B1 (en) 1997-03-12 2001-03-27 The University Of North Carolina At Chapel Hill Covalent conjugates of topoisomerase I and topoisomerase II inhibitors
WO1999032499A1 (en) * 1997-12-23 1999-07-01 Korea Research Institute Of Chemical Technology 4'-O-DEMETHYL-EPIPODOPHYLLOTOXIN-β-D-GLUCOSIDE ACETAL DERIVATIVES
WO2001024763A2 (en) 1999-10-01 2001-04-12 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US6624317B1 (en) 2000-09-25 2003-09-23 The University Of North Carolina At Chapel Hill Taxoid conjugates as antimitotic and antitumor agents
US6506739B1 (en) 2001-05-01 2003-01-14 Telik, Inc. Bis-(N,N'-bis-(2-haloethyl)amino)phosphoramidates as antitumor agents
BR0206206A (pt) * 2001-10-26 2005-01-11 Centre Nat Rech Scient Derivados de etoposide e análogos, e composições farmacêuticas contendo os mesmos
DK1537146T3 (da) 2002-07-15 2011-04-04 Univ Texas Antistoffer, der binder til anioniske phospholipider og aminophospholipider, og deres anvendelse til behandling af virusinfektioner
CA2516056C (en) * 2003-01-06 2012-05-29 Angiochem Inc. Aprotinin and analogs as carriers across the blood-brain barrier
CN100334090C (zh) * 2005-02-02 2007-08-29 南京医科大学 吡啶类鬼臼毒素化合物及其制备方法和在制备杀虫剂中的应用
US20090016959A1 (en) * 2005-02-18 2009-01-15 Richard Beliveau Delivery of antibodies to the central nervous system
SI1859041T2 (sl) * 2005-02-18 2015-04-30 Angiochem Inc. Polipeptidi aprotinina za prenos spojine prek krvno-moĹľganske pregrade
DK2233156T3 (da) * 2005-07-15 2013-08-05 Angiochem Inc Anvendelse af aprotininpolypeptider som bærere i farmaceutiske konjugater
CN100410266C (zh) * 2006-01-11 2008-08-13 重庆华邦制药股份有限公司 鬼臼毒素磷酸酯衍生物的合成方法
JO2660B1 (en) 2006-01-20 2012-06-17 نوفارتيس ايه جي Pi-3 inhibitors and methods of use
PE20070978A1 (es) * 2006-02-14 2007-11-15 Novartis Ag COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE FOSFATIDILINOSITOL 3-QUINASAS (PI3Ks)
AR060358A1 (es) * 2006-04-06 2008-06-11 Novartis Vaccines & Diagnostic Quinazolinas para la inhibicion de pdk 1
GB0625283D0 (en) * 2006-12-19 2007-01-24 Cyclacel Ltd Combination
US9365634B2 (en) * 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
WO2009036106A1 (en) * 2007-09-13 2009-03-19 Bristol-Myers Squibb Company Cytotoxic xanthone compounds
EP2614837A1 (en) 2007-11-09 2013-07-17 Affitech Research AS Anti-VEGF antibody compositions and methods
PE20091523A1 (es) 2007-12-20 2009-10-29 Novartis Ag Derivados de tiazol como inhibidores de la enzima fosfatidilinositol 3-cinasa (pi3k)
DK2279008T3 (en) * 2008-04-18 2019-04-29 Angiochem Inc PHARMACEUTICAL COMPOSITIONS OF PACLITAXEL, PACLITAXEL ANALOGS OR PACLITAXEL CONJUGATES AND RELATED PROCEDURES FOR PREPARATION AND USE
MX2011004017A (es) 2008-10-15 2011-06-24 Angiochem Inc Conjugados de agonistas glp-1 y usos de los mismos.
CN102245636A (zh) 2008-10-15 2011-11-16 安吉奥开米公司 用于药物递送的依托泊苷和多柔比星结合物
JP5759379B2 (ja) * 2008-12-05 2015-08-05 アンジオケム インコーポレーテッド ニューロテンシンまたはニューロテンシンアナログおよびその使用
WO2010069074A1 (en) 2008-12-17 2010-06-24 Universite Du Quebec A Montreal Membrane type-1 matrix metalloprotein inhibitors and uses thereof
JP2012524030A (ja) 2009-04-20 2012-10-11 アンジオケム インコーポレーテッド Angiopep−2アナログにコンジュゲート化した抗癌剤を用いた卵巣癌の治療
US8293753B2 (en) 2009-07-02 2012-10-23 Novartis Ag Substituted 2-carboxamide cycloamino ureas
BRPI1015918A2 (pt) 2009-07-02 2019-09-24 Angiochem Inc conjugados de peptídeo multiméricos e usos dos mesmos
RU2012139182A (ru) 2010-02-22 2014-03-27 Ф. Хоффманн-Ля Рош Аг ПИРИДО[3,2-d]ПИРИМИДИНЫ - ИНГИБИТОРЫ PI3К ДЕЛЬТА И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
US9586954B2 (en) 2010-06-22 2017-03-07 Demerx, Inc. N-substituted noribogaine prodrugs
AR082418A1 (es) 2010-08-02 2012-12-05 Novartis Ag Formas cristalinas de 1-(4-metil-5-[2-(2,2,2-trifluoro-1,1-dimetil-etil)-piridin-4-il]-tiazol-2-il)-amida de 2-amida del acido (s)-pirrolidin-1,2-dicarboxilico
PT2670753T (pt) 2011-01-31 2017-01-10 Novartis Ag Novos derivados heterocíclicos
US9617274B1 (en) 2011-08-26 2017-04-11 Demerx, Inc. Synthetic noribogaine
CN104039790B (zh) 2011-10-28 2016-04-13 诺华股份有限公司 嘌呤衍生物及它们在治疗疾病中的应用
JP2015500833A (ja) * 2011-12-09 2015-01-08 デメレックス, インコーポレイテッド ノルイボガインのリン酸エステル
EP2849756A1 (en) 2012-05-16 2015-03-25 Novartis AG Dosage regimen for a pi-3 kinase inhibitor
US9783535B2 (en) 2012-12-20 2017-10-10 Demerx, Inc. Substituted noribogaine
EP3076969B1 (en) 2013-12-06 2021-09-01 Novartis AG Dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhibitor
JP6823055B2 (ja) 2015-06-15 2021-01-27 アンジオケム インコーポレーテッド 軟髄膜癌腫症の治療方法
KR20180073674A (ko) 2015-11-02 2018-07-02 노파르티스 아게 포스파티딜이노시톨 3-키나제 억제제에 대한 투여 요법
WO2018060833A1 (en) 2016-09-27 2018-04-05 Novartis Ag Dosage regimen for alpha-isoform selective phosphatidylinositol 3-kinase inhibitor alpelisib
KR102378151B1 (ko) 2020-05-11 2022-03-24 주식회사 제이앤씨사이언스 베타-아포피크로포도필린의 신규한 유도체

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1171314A (fr) * 1955-05-13 1959-01-23 Sandoz Ag Produits de condensation de glucosides avec des composés carbonyliques et leur préparation
NL6613143A (it) * 1965-09-21 1967-03-22
CH464957A (de) * 1965-12-14 1968-11-15 Sandoz Ag Verfahren zur Herstellung eines neuen Glucosids
CH481096A (de) * 1966-12-13 1969-11-15 Sandoz Ag Verfahren zur Herstellung neuer Glucoside
CH514578A (de) * 1968-02-27 1971-10-31 Sandoz Ag Verfahren zur Herstellung von Glucosiden
CH543502A (de) * 1970-11-20 1973-10-31 Sandoz Ag Verfahren zur Herstellung neuer Glucoside
GB1395820A (en) * 1971-06-05 1975-05-29 Villax I Preparation of 21-inorganic esters of corticosteroids and salts thereof
CH589668A5 (en) * 1973-06-07 1977-07-15 Sandoz Ag Cytostatic (4')-demethyl substd. epipodophyllotoxin - prepd. from the corresp. glucopyranoside with (3)-thiophene-carboxaldehyde
FR2397425A1 (fr) * 1977-07-11 1979-02-09 Rhone Poulenc Ind Nouveaux derives de la daunorubicine, leur preparation et les compositions qui les contiennent
DE3374317D1 (en) * 1982-11-26 1987-12-10 Nippon Kayaku Kk Process for producing 4'-demethyl-epipodophyllotoxin-beta-d-ethylidene-glucoside and acyl-derivative thereof
US4567253A (en) * 1984-02-03 1986-01-28 Tony Durst 2-Substituted derivatives of podophyllotoxin and etoposide
JPS60208910A (ja) * 1984-03-31 1985-10-21 Green Cross Corp:The 水難溶性薬物・リン脂質複合体の製造方法
JPS60246393A (ja) * 1984-05-22 1985-12-06 Nippon Kayaku Co Ltd エトポシドの新規製造法
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
IL77334A (en) * 1985-12-16 1991-04-15 Univ Bar Ilan Synthesis of 9-epipodophyllotoxin glucoside derivatives and some novel intermediates therefor
US4916217A (en) * 1987-01-08 1990-04-10 Bristol-Myers Company Phosphorus containing derivatives of epipodophyllotoxin
JPS63192793A (ja) * 1987-02-06 1988-08-10 Nippon Kayaku Co Ltd 4′−デメチル−エピポドフイロトキシン誘導体の新規エステル
US4874851A (en) * 1987-07-01 1989-10-17 Bristol-Meyers Company 3',4'-dinitrogen substituted epipodophyllotoxin glucoside derivatives

Also Published As

Publication number Publication date
LU90138I2 (fr) 1997-11-26
DE3826562C2 (it) 1993-04-08
NO920277D0 (no) 1992-01-22
FI883596A (fi) 1989-02-05
DD299067A5 (de) 1992-03-26
NO172440C (no) 1993-07-21
NO1998002I1 (no) 1998-01-14
NO920277L (no) 1989-02-24
HU208147B (en) 1993-08-30
JPH01100188A (ja) 1989-04-18
AU610619B2 (en) 1991-05-23
PT88186A (pt) 1989-06-30
SE8802815L (sv) 1989-02-05
DK434088D0 (da) 1988-08-03
KR890003790A (ko) 1989-04-18
NL970042I1 (nl) 1998-03-02
HUT47303A (en) 1989-02-28
SG101291G (en) 1992-01-17
DK434088A (da) 1989-02-05
ES2010775A6 (es) 1989-12-01
SE502214C2 (sv) 1995-09-18
BE1002982A4 (fr) 1991-10-15
SK541288A3 (en) 1998-10-07
CZ286893B6 (cs) 2000-07-12
SK279325B6 (sk) 1998-10-07
HU211960A9 (en) 1996-01-29
KR900006230B1 (ko) 1990-08-27
GR1000490B (el) 1992-07-30
DE3826562A1 (de) 1989-02-16
MX173843B (es) 1994-03-30
ATA195588A (de) 1994-07-15
IT1226825B (it) 1991-02-19
USRE35524E (en) 1997-06-03
YU10490A (en) 1990-06-30
GB2207674A (en) 1989-02-08
CZ541288A3 (cs) 1999-12-15
FI87790B (fi) 1992-11-13
GR880100512A (en) 1989-05-25
DK11992D0 (da) 1992-01-31
NO883299L (no) 1989-02-24
NL8801934A (nl) 1989-03-01
SE8802815D0 (sv) 1988-08-03
NO920665D0 (no) 1992-02-20
NO172440B (no) 1993-04-13
NL192683B (it) 1997-08-01
CN1027169C (zh) 1994-12-28
AT398974B (de) 1995-02-27
NO170284B (no) 1992-06-22
FR2622193A1 (fr) 1989-04-28
FI87790C (fi) 1993-02-25
CY1625A (en) 1992-07-10
NL970042I2 (it) 2005-06-01
IE882378L (en) 1989-02-04
DK11992A (da) 1992-01-31
CA1310637C (en) 1992-11-24
AU2030688A (en) 1989-06-08
LU87290A1 (fr) 1990-02-07
PT88186B (pt) 1995-07-03
HU202547B (en) 1991-03-28
YU143688A (en) 1990-04-30
DD274423A5 (de) 1989-12-20
IL87290A (en) 1993-01-31
US4904768A (en) 1990-02-27
MY104321A (en) 1994-03-31
YU10390A (en) 1990-06-30
IL87290A0 (en) 1989-01-31
NZ225615A (en) 1991-06-25
FI883596A0 (fi) 1988-08-01
GB8818462D0 (en) 1988-09-07
FR2622193B1 (fr) 1993-12-17
CN1061225A (zh) 1992-05-20
NO920665L (no) 1989-02-24
NL192683C (nl) 1997-12-02
DK169344B1 (da) 1994-10-10
NO170284C (no) 1992-09-30
CH676716A5 (it) 1991-02-28
GB2207674B (en) 1991-09-11
IE61040B1 (en) 1994-09-07
NO883299D0 (no) 1988-07-26
HU905862D0 (en) 1991-03-28
US5041424A (en) 1991-08-20
MX9202851A (es) 1992-06-30
JPH0699465B2 (ja) 1994-12-07
HK6392A (en) 1992-01-17

Similar Documents

Publication Publication Date Title
IT8821535A0 (it) Derivati 4' fosfato di glucosidi della epipodofillotossina e relative composizioni farmaceutiche.
NZ222527A (en) N 9 -cyclopentyl-substituted adenosine derivatives and intermediate compound and pharmaceutical compositions
IT8848714A0 (it) Derivati di adenosina, composizioni farmaceutiche che li contengono erelativo procedimento di preparazione ed appplicazione
NZ235726A (en) Substituted pyrimidine derivatives; their preparation and pharmaceutical compositions
MX9203027A (es) Derivados heterociclicos de acilaminotiazoles y composicines farmaceuticas que los contienen.
IL92558A0 (en) Pharmaceutical compositions comprising pyrimidine derivatives,certain novel such derivatives and their preparation
NZ224714A (en) Substituted benzotriazole derivatives and pharmaceutical compositions
NZ221996A (en) Imidazo-pyridine derivatives and pharmaceutical compositions
NZ220171A (en) Dihydro-benzopyran derivatives and pharmaceutical compositions
NZ215186A (en) 13 alkoxymethoxy avermectin derivatives and pharmaceutical compositions
IT8848619A0 (it) Derivati di lisosfingolipidi
NZ223384A (en) Benzopyran derivatives and pharmaceutical compositions
IT1208807B (it) Derivati di 1 3 ossazolidin 2 one e procedimenti per la loro preparazione
PT87024A (pt) Process for the preparation of propiolophenone derivatives and of pharmaceutical compositions containing the same
PT87550A (pt) Process for the preparation of pyrimidine derivatives and of pharmaceutical compositions containing the same
NZ225613A (en) Benzazepin-2-one derivatives and pharmaceutical compositions
MX9203613A (es) Derivados de adenosina y composiciones farmaceuticas que los contienen.
NZ233013A (en) Substituted thieno-triazolo-diazepine derivatives and pharmaceutical compositions
IT8723280A0 (it) Derivati della 3 piperidinocarbaldeide ossima, loro procedimento di preparazione e loro applicazione come farmaci
IL87586A (en) 3(-demethoxypipo- dophyllotoxin glucoside derivatives and pharmaceutical compositions containing them
NZ223051A (en) Carbamoyloxylabdane derivatives and pharmaceutical compositions
NZ227235A (en) Substituted 1,5-benzothiazepin-4-one derivatives and pharmaceutical compositions
MX9203616A (es) Derivados de 4-amidino cromano y de 4-amidino[3,2-c] piridina y composiciones farmaceuticas que los contienen.
IT8821570A0 (it) Impiego di derivati adenosinici per la preparazione di composizioni farmaceutiche aventi attivita' immunostimolante.
NZ220677A (en) 7-oxabicycloheptane derivatives and pharmaceutical compositions

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970730